Brenntag will showcase forward-looking formulations designed to respond to Indonesia’s evolving beauty and self-care needs
The platform is being introduced to expand access to treatments for people living with chronic conditions
Expanded capabilities that continue to push the boundaries of innovation—advancing drug delivery solutions for patients, customers, and consumers around the world
The lab will facilitate the development of herbal and natural-based solutions
The FDA is beginning rulemaking to close the “adequate provision” loophole
AHLL will become a 100% subsidiary of AHEL with 99.42% held by AHEL and balance in the ESOP pool
Maria Soler Nunez appointed as Chief Quality Officer
Transformation to increase speed and redirect resources to growth opportunities within diabetes and obesity, aiming at reaching millions of untreated patients
Subscribe To Our Newsletter & Stay Updated